Latest Headlines

  1. Portal Innovations Selected As Ocean State Labs Incubator Partner 3/31/2025

    The Rhode Island Life Science Hub and Brown University selected Portal Innovations (Portal) as the manager of their state-of-the-art life science incubator, Ocean State Labs.

  2. GenomOncology Partners With Chronetyx Laboratories To Accelerate Cancer Care Through Comprehensive Genomic Profiling 3/31/2025

    GenomOncology, a precision medicine software company, today announced a strategic partnership with Chronetyx Laboratories, a leading provider of advanced diagnostic solutions, that will significantly reduce turnaround times for next-generation sequencing (NGS) testing results and streamline cancer care delivery.

  3. Antithrombin Blood Test From Siemens Healthineers Now FDA Cleared As A Companion Diagnostic For Qfitlia, A Sanofi Hemophilia Therapy 3/28/2025

    Siemens Healthineers announced today its Innovance Antithrombin assay has achieved FDA clearance for a new claim allowing it to be used as a companion diagnostic test for people receiving treatment with Qfitlia (fitusiran), a Sanofi hemophilia therapy.1

  4. Daxor Expands Blood Volume Analysis Technology Across Midwest, Wisconsin, And New Jersey Healthcare Networks 3/28/2025

    Daxor Corporation (Nasdaq: DXR), Daxor, the global leader in blood volume measurement technology, today announces a significant expansion into three regional healthcare facilities across the U.S. These facilities will use Daxor's Tennessee-based ezBVA Lab, a CLIA-certified facility equipped with state-of-the-art technology.

  5. Mayo Clinic Laboratories And Amprion Announce Collaboration To Advance Neurodegenerative Disease Diagnostics 3/26/2025

    Mayo Clinic Laboratories and Amprion, a global leader advancing diagnosis of neurodegenerative disorders through seed amplification testing, today announced a collaboration to expand access to Amprion's SAAmplify–αSYN (CSF) test across the United States.

  6. BetterWay Blood Testing By Babson Diagnostics To Expand To Sam's Clubs In The Austin Area 3/26/2025

    BetterWay™ blood testing by Babson Diagnostics today announced that it has entered into an agreement with Sam's Club, a division of Walmart Inc., to offer friendly, convenient, and affordable blood testing.

  7. Applied DNA Submits Validation Package To New York State Department Of Health For H5 Bird Flu/Pan-Influenza A Laboratory-Developed Test 3/26/2025

    Applied DNA Sciences, Inc. (Applied DNA or the "Company"), a leader in PCR-based DNA technologies, today announced that Applied DNA Clinical Labs (ADCL), the Company's wholly-owned clinical laboratory subsidiary, has submitted a validation package to the New York State Department of Health (NYSDOH) to request approval as a laboratory-developed test (LDT) for a PCR-based assay for the detection and subtyping of influenza A (H5) virus, also known as H5 bird flu, highly pathogenic avian influenza, or H5N1 (collectively "H5 bird flu").

  8. CS Analytical Extends High Voltage Leak Testing Capabilities With Addition Of Nikka Densok HDL-1 HVLD Test System 3/25/2025

    CS Analytical Laboratory, the world's only cGMP, FDA-registered and inspected contract laboratory exclusively designed and dedicated to container testing for the pharmaceutical, biotechnology, and medical device industries, is excited to announce that it has acquired, installed and qualified a Nikka Densok HDL-1 High Voltage Leak Detection Instrument to improve our capabilities for USP 1207 Container Closure Integrity Testing.

  9. Belay Diagnostics Partners With GenomOncology To Support High-Performance Liquid Biopsy Test For Central Nervous System Cancer Detection 3/25/2025

    Belay Diagnostics announces its partnership with GenomOncology (GO), a precision medicine software company that provides data-driven tools and resources to improve cancer care.

  10. Aditxt Subsidiary Pearsanta Completes The Acquisition Of Proprietary Adductomics Technology To Develop And Advance The Platform Toward Clinical And Commercial Applications For Monitoring Early Signs Of Increased Cancer Risk 3/24/2025

    Aditxt, Inc. ("Aditxt" or the "Company"), a social innovation platform accelerating promising health innovations, today announced that its subsidiary, Pearsanta, Inc. ("Pearsanta"), has acquired key patents related to adductomics-based DNA damage detection, which it believes will further strengthen its position in the cancer prevention-focused diagnostic industry.